Sihuan Pharmaceutical Holdings Group ( (HK:0460) ) has provided an announcement.
Sihuan Pharmaceutical Holdings Group Ltd. announced a share repurchase plan of up to HK$500 million, with a recent repurchase of 10 million shares at an average price of HK$0.6274 per share. This move is part of the company’s strategic goal to strengthen its market position in medical aesthetics and biopharmaceuticals, with significant growth reported in its medical aesthetics segment and ongoing development of innovative drugs. The company expects these developments to positively impact its revenue and profit, reinforcing its confidence in future growth.
More about Sihuan Pharmaceutical Holdings Group
Founded in 2001 and listed on the Main Board of the Stock Exchange in 2010, Sihuan Pharmaceutical is an international medical aesthetics and biopharmaceutical company led by innovation. It boasts an independent research and development technology platform, a global product pipeline, strong product registration capability, and a mature sales system. The company aims to be a leader in medical aesthetics and biopharmaceuticals in China.
YTD Price Performance: 142.00%
Average Trading Volume: 200
Technical Sentiment Signal: Sell
Current Market Cap: $757.8M
Find detailed analytics on 0460 stock on TipRanks’ Stock Analysis page.